688222

HitGen
688222

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
CN¥6.66B
EV
CN¥5.90B
Shares Outstanding
399.44M
Beta
0.12

Wall Street View

Analyst Rating
BUY
Analyst Target Price
CN¥15.53
P/E 2025E
102.64x
P/Revenue 2025E
12.62x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About HitGen Inc.

gainify
688222

HitGen Inc.

688222

HitGen Inc. operates as a drug discovery research platform for small molecules and nucleic acid drugs in China and internationally. Its technology platform includes DNA-encoded library technology; fragment-based drug discovery and structure-based drug design technolog...

Sector

Industry

CEO

Jin, Li

Employees

483

IPO Date

Headquarters

Building 6, No.8, Huigu 1st East Road, Tianfu International Bio-Town, Shuangliu District, Chengdu, Sichuan Province, 610200, China

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.